Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session of management of psoriatic arthritis and spondyloarthritis.
In this webinar, an elaborate discussion on different rheumatological diseases like psoriatic arthritis and spondyloarthritis is done. The primary subject of discussion in this webinar is immunological responses in rheumatic diseases. Treatment approaches like use of DMARDs, NSAIDs etc are the primary focus of discussion.
The speakers Dr Lata Bichile, Dr Puja Srivastava, and Dr Abhrajit Ray have immense knowledge and experience in the field of rheumatology and have given important insights in managing the diseases. In this webinar they have discussed how psoriatic arthritis is different from psoriasis and how the management of spondyloarthritis can be done.
Psoriatic arthritis is similar to rheumatoid arthritis (RA) in terms of symptoms and joint swelling (inflammation). And spondyloarthritis is a type of arthritis that attacks the spine and, in some people, the joints of the arms and legs
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Beyond What Is Visible in Myelofibrosis?
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Certain surgical gestures during prostate removal linked to better sexual function recovery
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation